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The Nucleophosmin-Pin1 interaction links the cell cycle, cancer and pluripotency 
In the current issue of J Mol Biochem, Zhao et al. 
(2015) characterize the phosphorylation sites of nu-
cleophosmin (Npm); a protein involved, among others, 
in licensing of centrosome duplication during the cell 
cycle. The authors also identify a functional interaction 
of Npm with the Pin1 isomerase, taking place during 
mitosis. They show that mutating one of the possible 
Npm binding sites results in cell division defects and a 
decrease in mitotic cell number. The latter is of special 
significance, suggesting that Npm post -
phosphorylation plays a role in cell cycle progression. 
But perhaps the most interesting aspect in this story is 
the emerging link between the cell cycle, cancer and 
pluripotency. 
 Excessive centrosome numbers have been re-
ported to disrupt proper chromosome segregation, 
which, in turn, is correlated to oncogenesis (Godinho 
& Pellman 2014). In line with this, high Pin1 expres-
sion has been reported in a plethora of human cancers 
(Bao et al. 2004), and has been associated with poor 
prognosis (reviewed by Lu & Hunter 2014). Its over-
expression has been reported to induce chromosomal 
instability, in vitro cell transformation as well as 
malignant mammary tumors in transgenic mice 
(Suizu et al. 2006). In addition, Npm is overex-
pressed in a large number of human cancers 
(reviewed by Grisendi et al. 2006) and has been 
proposed to have oncogenic properties (Lim & Wang 
2006) but its ablation has also been linked to centro-
some overduplication and genomic instability 
(Grisendi et al. 2005). 
 Interestingly, both NPM and Pin1 are linked to 
pluripotency. The former was first identified in a ge-
nome-wide screen for pluripotency regulators; further 
analysis suggested that it promotes the self-renewal of 
embryonic stem (ES) cells via the RNA-binding pro-
tein Mki67ip (Abujarour et al. 2010). In line with this, 
Johansson and Simonsson (2010) found that, in ES 
cells, each of the core ES cell transcription factors 
Oct4, Sox2 and Nanog independently formed com-
plexes with Npm1. They further showed that these in-
teractions were affected by the routes of differentiation 
and that Npm1 downregulation increased the expres-
sion of mesodermal and ectodermal genes, while they 
identified that Npm also interacts with Translationally 
controlled tumor protein (Tpt1) during ES cell mitosis 
(Johansson et al. 2010). Similarly, Pin1 was found to 
interact and stabilise Nanog, a critical mechanism for 
their ability to self-renew and form teratomas in mice 
(Moretto-Zita et al. 2010). Nishi et al. (2011) showed 
that Pin1 also regulates phosphorylated Oct4 and is 
essential for the maintenance of the pluripotent state. 
 All the above can be seen within a new con-
text, with the novel identification of Npm-Pin1 interac-
tion, reported in this issue. The interplay between the 
cell cycle, pluripotency and cancer  has only recently 
gained attention and seems to be extremely compli-
cated and multidirectional (Champeris Tsaniras et al. 
2014); however, a better understanding is on the way, 
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